Polaprezinc reduces paclitaxel-induced peripheral neuropathy in rats without affecting anti-tumor activity

Paclitaxel, an anticancer drug, frequently causes painful peripheral neuropathy. In this study, we investigated the preventive effect of polaprezinc on paclitaxel-induced peripheral neuropathy in rats. Polaprezinc (3 mg/kg, p.o., once daily) inhibited the development of mechanical allodynia induced...

Full description

Bibliographic Details
Main Authors: Kuniaki Tsutsumi, Takanori Kaname, Haruka Shiraishi, Takehiro Kawashiri, Nobuaki Egashira
Format: Article
Language:English
Published: Elsevier 2016-06-01
Series:Journal of Pharmacological Sciences
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1347861316300366
_version_ 1811314112298221568
author Kuniaki Tsutsumi
Takanori Kaname
Haruka Shiraishi
Takehiro Kawashiri
Nobuaki Egashira
author_facet Kuniaki Tsutsumi
Takanori Kaname
Haruka Shiraishi
Takehiro Kawashiri
Nobuaki Egashira
author_sort Kuniaki Tsutsumi
collection DOAJ
description Paclitaxel, an anticancer drug, frequently causes painful peripheral neuropathy. In this study, we investigated the preventive effect of polaprezinc on paclitaxel-induced peripheral neuropathy in rats. Polaprezinc (3 mg/kg, p.o., once daily) inhibited the development of mechanical allodynia induced by paclitaxel (4 mg/kg, i.p., on days 1, 3, 5 and 7) and suppressed the paclitaxel-induced increase in macrophage migration in dorsal root ganglion cells. In addition, polaprezinc did not affect the anti-tumor activity of paclitaxel in cultured cell lines or tumor-bearing mice. These results suggest a clinical indication for polaprezinc in the prevention of paclitaxel-induced neuropathy.
first_indexed 2024-04-13T11:06:09Z
format Article
id doaj.art-f7573b8aee2a406482c7393c09affe3b
institution Directory Open Access Journal
issn 1347-8613
language English
last_indexed 2024-04-13T11:06:09Z
publishDate 2016-06-01
publisher Elsevier
record_format Article
series Journal of Pharmacological Sciences
spelling doaj.art-f7573b8aee2a406482c7393c09affe3b2022-12-22T02:49:16ZengElsevierJournal of Pharmacological Sciences1347-86132016-06-01131214614910.1016/j.jphs.2016.04.019Polaprezinc reduces paclitaxel-induced peripheral neuropathy in rats without affecting anti-tumor activityKuniaki TsutsumiTakanori KanameHaruka ShiraishiTakehiro KawashiriNobuaki EgashiraPaclitaxel, an anticancer drug, frequently causes painful peripheral neuropathy. In this study, we investigated the preventive effect of polaprezinc on paclitaxel-induced peripheral neuropathy in rats. Polaprezinc (3 mg/kg, p.o., once daily) inhibited the development of mechanical allodynia induced by paclitaxel (4 mg/kg, i.p., on days 1, 3, 5 and 7) and suppressed the paclitaxel-induced increase in macrophage migration in dorsal root ganglion cells. In addition, polaprezinc did not affect the anti-tumor activity of paclitaxel in cultured cell lines or tumor-bearing mice. These results suggest a clinical indication for polaprezinc in the prevention of paclitaxel-induced neuropathy.http://www.sciencedirect.com/science/article/pii/S1347861316300366PaclitaxelPeripheral neuropathyPolaprezinc
spellingShingle Kuniaki Tsutsumi
Takanori Kaname
Haruka Shiraishi
Takehiro Kawashiri
Nobuaki Egashira
Polaprezinc reduces paclitaxel-induced peripheral neuropathy in rats without affecting anti-tumor activity
Journal of Pharmacological Sciences
Paclitaxel
Peripheral neuropathy
Polaprezinc
title Polaprezinc reduces paclitaxel-induced peripheral neuropathy in rats without affecting anti-tumor activity
title_full Polaprezinc reduces paclitaxel-induced peripheral neuropathy in rats without affecting anti-tumor activity
title_fullStr Polaprezinc reduces paclitaxel-induced peripheral neuropathy in rats without affecting anti-tumor activity
title_full_unstemmed Polaprezinc reduces paclitaxel-induced peripheral neuropathy in rats without affecting anti-tumor activity
title_short Polaprezinc reduces paclitaxel-induced peripheral neuropathy in rats without affecting anti-tumor activity
title_sort polaprezinc reduces paclitaxel induced peripheral neuropathy in rats without affecting anti tumor activity
topic Paclitaxel
Peripheral neuropathy
Polaprezinc
url http://www.sciencedirect.com/science/article/pii/S1347861316300366
work_keys_str_mv AT kuniakitsutsumi polaprezincreducespaclitaxelinducedperipheralneuropathyinratswithoutaffectingantitumoractivity
AT takanorikaname polaprezincreducespaclitaxelinducedperipheralneuropathyinratswithoutaffectingantitumoractivity
AT harukashiraishi polaprezincreducespaclitaxelinducedperipheralneuropathyinratswithoutaffectingantitumoractivity
AT takehirokawashiri polaprezincreducespaclitaxelinducedperipheralneuropathyinratswithoutaffectingantitumoractivity
AT nobuakiegashira polaprezincreducespaclitaxelinducedperipheralneuropathyinratswithoutaffectingantitumoractivity